☆ 4.2 Editorial Material

Long-term Remission by Brentuximab Vedotin for Non-mediastinal Gray Zone Lymphoma Refractory to Autologous Stem Cell Transplantation

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)

Journal

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Volume 19, Issue 11, Pages E602-E604

Publisher

CIG MEDIA GROUP, LP

DOI: 10.1016/j.clml.2019.08.017

Keywords

CD30 positive lymphoma; Refractory lymphoma; Salvage treatment; Targeted therapy

Categories

Oncology Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.